Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation
- 1 February 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (3) , 1158-1165
- https://doi.org/10.1182/blood-2003-04-1098
Abstract
Eliminating alloreactive cells from T-cell populations would enable the transfer of immune function to patients who receive stem cell transplants. However, high-efficiency depletion has proved difficult to achieve. We sought to develop ex vivo approaches for the maximal depletion of alloreactive CD4+ T cells. Using a flow cytometric cell sorting approach after mixed lymphocyte reaction (MLR) culture, we have found that sorted CFSEbright (5-(and-6)-carboxyfluorescein diacetate succinmidyl ester) (nondivided) and activation antigen-negative cells are markedly depleted of alloreactivity. With HLA-mismatched peripheral blood mononuclear cell (PBMC) stimulators we have consistently attained (90%-95%) depletion of alloreactivity. Importantly, when purified matured monocyte-derived dendritic cells (DCs) are used as stimulators, a 100-fold (99%) reduction in alloreactivity was attained, resulting in abrogation of the secondary MLR. Significantly, the CFSEbright CD25- cells recovered from these cultures retained general immunoreactivity, including responses to Candida and cytomegalovirus (CMV) antigens. In addition, a CFSE-based approach was tested and found to be sufficient for graft-versus-host disease (GVHD) prevention in vivo, in a major histocompatibility complex (MHC) class II disparate murine model. This efficient approach to selectively deplete mature alloantigen-specific T cells may permit enhanced immune reconstitution without GVHD. (Blood. 2004;103:1158-1165)Keywords
This publication has 36 references indexed in Scilit:
- Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responsesBlood, 2003
- Immunobiology of Dendritic CellsAnnual Review of Immunology, 2000
- Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft‐versus‐host diseaseBritish Journal of Haematology, 1999
- Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxisBone Marrow Transplantation, 1999
- CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.Journal of Clinical Investigation, 1998
- Specific depletion of alloreactive T cells in HLA‐identical siblings: a method for separating graft‐versus‐host and graft‐versus‐leukaemia reactionsBritish Journal of Haematology, 1998
- Recent advances in graft‐versus‐host disease (GVHD) preventionImmunological Reviews, 1997
- CIITA activates the expression of MHC class II genes in mouse T cellsInternational Immunology, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- SPECIFIC ELIMINATION OF ALLOREACTIVE T CELLS BY AN ANTI-INTERLEUKIN-2 RECEPTOR B CHAIN-SPECIFIC IMMUNOTOXINTransplantation, 1990